Being AI/Announcement
Being AI logo

Half year results

Half Year Results27 November 2023BAIHealthcare

1
Ascension Capital Limited


Ascension Capital Limited (NZX: ACE)


The Board of Ascension Capital Limited (NZX: ACE) has today announced the unaudited half-year

financial results of the business for the six months ended 30 September 2023.


Half year results announcement for the six months ended 30 September 2023


Results for announcement to the market

Name of issuer Ascension Capital Limited (NZX: ACE)

Reporting Period 6 months to 30 September 2023

Previous Reporting Period 6 months to 30 September 2022

Currency NZD

Amount (000s) Percentage change

Revenue from continuing

operations

$- -%

Total Revenue $- -%

Net profit/(loss) from

continuing operations

$(86) 3.6%

Total net profit/(loss) $(86) 3.6%

Interim/Final Dividend

Amount per Quoted Equity

Security

The company does not propose to pay a dividend at this time.

Imputed amount per Quoted

Equity Security

Not applicable

Record Date Not applicable

Dividend Payment Date Not applicable

Current period Prior comparable period

Net tangible assets per Quoted

Equity Security

As at 30 September 2023

$(0.0381)


As at 30 September 2022

$(0.0375)

A brief explanation of any of

the figures above necessary to

enable the figures to be

understood

Refer to the unaudited interim financial statements that accompany

this announcement.

Authority for this announcement

Name of person authorised to

make this announcement

Sean Joyce

Contact person for this

announcement

Sean Joyce,

2
Contact phone number +64 21 865 704

Contact email address sean@corporate-counsel.co.nz

Date of release through MAP 28 November 2023


Unaudited financial statements accompany this announcement.

---

Ascension Capital Limited


Condensed Interim Financial Statements



For the six months ended 30 September 2023







Ascension Capital Limited

Condensed Interim Financial Statements

For the six months ended 30 September 2023




1

Contents


Letter from the Chair 2

Statement of Profit or Loss and Other Comprehensive Income 4

Statement of Changes in Equity 5

Statement of Financial Position 6

Statement of Cash Flows 7

Condensed Notes to the Interim Financial Statements 8

Company Directory 14









Ascension Capital Limited

Letter from the Chair

For the six months ended 30 September 2023




2

28 November 2023



Dear Shareholders



The financial result of the Company for the six months ended 30 September 2023 is a loss after taxation of

NZ$86,370, largely made up of directors’ fees, NZX listing costs and legal and accounting costs. This is a

net increase in costs of $2,984 compared to the 1st half of the previous year.

The operating cashflow requirements of $61,595 for the half year period were financed through an issue of

2,350,000 new ordinary fully paid shares in April 2023 at an issue price of $0.029 per share, to a number of

wholesale investors.

The agreement with the directors to continue to forego the payment of directors’ fees until such time as the

Company has sufficient funds to make such payments, continues.

There were no changes in the board of directors during the period.

Sean Joyce, a director of the Company, through one of his investment vehicles, continues to provide

financial support to the Company to ensure that the Company is able to meet its cash flow requirements.

The Board is actively looking to identify a suitable business opportunity to invest in and/or acquire through a

reverse takeover transaction (RTO). Discussions have been had with several potential acquisition parties, but

none of those discussions have developed into a tangible transaction to date.


An RTO is a transaction structured such that the Company would acquire 100% of the business assets, or the

shares in the company that owns the business assets, in consideration for the payment of cash and/or the

issue of new shares in the Company, to the vendors, to fund the acquisition.


The new business acquired would then effectively become a subsidiary of the Company (the listed company),

trading on the NZX Main Board. The stakeholders in the business acquired, would ultimately become

shareholders in the Company as part of the RTO, and would have representation at the Board level as

appropriate.


In conjunction with the RTO process, the Company would seek to raise additional growth capital to assist in

funding the future growth of the business.


The Board is focusing on business opportunities that satisfy one or more of the following investment criteria:

• The business has excellent personnel and management.

• The business operates in an attractive and positive business sector.

• The business has a robust business model.

• The business has solid historical earnings, or alternatively has a sound business platform from which

to implement its business plan and generate strong earnings in the future.

• The business owns proprietary intellectual property.

• The business has potential to grow organically, via acquisition, or through the further investment in

capital plant.

• The business has the potential to scale internationally.

• The business would benefit from being able to raise additional capital on the market.

• Is likely to generate superior returns for the Company and its existing shareholders.



Ascension Capital Limited

Letter from the Chair

For the six months ended 30 September 2023




3

The Board continues to investigate all credible investment opportunities that may present themselves and are

hopeful of having a transaction underway during the course of the current financial year.


We thank you for your continued patience and support and we look forward to providing you with an RTO

transaction proposal to consider in the near future.


Yours sincerely




Keith Jackson

Chair



Ascension Capital Limited

Statement of Profit or Loss and Other Comprehensive Income

For the six months ended 30 September 2023



These interim financial statements have not been audited, nor reviewed by the auditor. The accompanying notes

form part of these interim financial statements and should be read in conjunction with them.


4





6 mths ended

6 mths ended

30 Sep 2023

30 Sep 2022

Note

(unaudited)

(unaudited)

NZ$

NZ$

Interest income

411

137

Total operating income

411

137

Operating expenses

3

(84,406)

(81,627)

Finance costs

(2,375)

(1,896)

Operating loss before tax

(86,370)

(83,386)

Tax expense

-

-

Net loss for the period

(86,370)

(83,386)

Other comprehensive income

Other comprehensive income for the period, net of tax

-

-

Total comprehensive loss attributable to shareholders

(86,370)

(83,386)

Earnings/(loss) per share from continuing operations:

- basic and diluted loss per share (NZ$)

5

(0.00406)

(0.00435)



Ascension Capital Limited

Statement of Changes in Equity

For the six months ended 30 September 2023



These interim financial statements have not been audited, nor reviewed by the auditor. The accompanying notes

form part of these interim financial statements and should be read in conjunction with them.


5






Note

Share

Accumulated

Total

capital

losses

equity

NZ$

NZ$

NZ$

Balance at 1 April 2022 (audited)

16,071,545

(16,706,758)

(635,213)

Total comprehensive income

Net loss attributable to shareholders

-

(83,386)

(83,386)

Balance at 30 September 2022 (unaudited)

16,071,545

(16,790,144)

(718,599)

Balance at 1 April 2023 (audited)

16,071,545

(16,867,266)

(795,721)

Transactions with owners

Ordinary shares issued

8

68,150

-

68,150

Less costs of share issue

8

(4,578)

-

(4,578)

63,572

-

63,572

Total comprehensive income

Net loss attributable to shareholders

-

(86,370)

(86,370)

Balance at 30 September 2023 (unaudited)

16,135,117

(16,953,636)

(818,519)



Ascension Capital Limited

Statement of Financial Position

As at 30 September 2023



These interim financial statements have not been audited, nor reviewed by the auditor. The accompanying notes

form part of these interim financial statements and should be read in conjunction with them.


6







For and on behalf of the Board:





Director Director


Dated: 28 November 2023


30 Sep 2023

31 Mar 2023

Note

(unaudited)

(audited)

NZ$

NZ$

ASSETS

Current assets

Cash and cash equivalents

2,530



550

Other current assets

13,757



4,726

Taxation receivable

82



81

Term deposit - NZX bond

21,519



21,111

Total current assets

37,888



26,468



LIABILITIES

Current liabilities

Trade and other payables

64,392



72,548

Payables to directors

309,999



270,000

Related party advances (unsecured)

6

482,016



479,641

Total current liabilities

856,407



822,189



Net assets (liabilities)

(818,519)

(795,721)

EQUITY

Share capital

8

16,135,117



16,071,545

Accumulated losses

(16,953,636)

(16,867,266)

Total equity

(818,519)

(795,721)



Ascension Capital Limited

Statement of Cash Flows

For the six months ended 30 September 2023



These interim financial statements have not been audited, nor reviewed by the auditor. The accompanying notes

form part of these interim financial statements and should be read in conjunction with them.


7



6 mths ended6 mths ended

30 Sep 202330 Sep 2022

(unaudited)(unaudited)

Note

NZ$NZ$

Cash flows from operating activities

Payments to suppliers(61,386)(59,050)

Income tax refunded (paid)(209)-

Net cash used in operating activities

7

(61,595)(59,050)

Cash flows from investing activities

Interest received

3-

Net cash flows from investing activities3-

Cash flows from financing activities

Borrowings from related party-60,000

Cash proceeds from issue of shares863,572-

Net cash flows from financing activities63,57260,000

Net increase in cash and cash equivalents1,980950

Cash and cash equivalents at the beginning of the period5504,080

Cash and cash equivalents at the end of the period

2,5305,030



Ascension Capital Limited

Condensed Notes to the Interim Financial Statements

For the six months ended 30 September 2023


8

1. General information

These unaudited condensed interim financial statements are for Ascension Capital Limited (“Ascension” or

“the Company”).

Ascension is a limited liability company incorporated and domiciled in New Zealand. Its registered office is

at c/- Duncan Cotterill Lawyers, Level 5, Tower Building, 50 Customhouse Quay, Wellington.

The Company is currently non trading and is focused on identifying a suitable business opportunity to

invest in and/or acquire through a reverse take-over transaction. There are no seasonal or cyclical

influences on these interim results.


2. Summary of Significant Accounting Policies

2.1. Basis of preparation

These unaudited condensed interim financial statements have been prepared in accordance New Zealand

Generally Accepted Accounting Practice (“NZ GAAP”), with New Zealand Equivalent to International

Accounting Standard 34: Interim Financial Reporting (“NZ IAS 34”) and with International Accounting

Standard 34: Interim Financial Reporting (“IAS 34”).

Ascension is a company registered under the Companies Act 1993 and is an FMC reporting entity under

the Financial Markets Conduct Act 2013. The Company is listed on the NZX Market. These interim

financial statements have been prepared in accordance with the requirements of the Financial Markets

Conduct Act 2013 and the NZX Main Board Listing Rules.

The condensed interim financial statements do not include all of the notes of the type normally included in

an annual financial report. Accordingly, this report should be read in conjunction with the financial

statements included in the annual report for the year ended 31 March 2023 which have been prepared in

accordance with New Zealand equivalents to International Financial Reporting Standards (“NZ IFRS”) and

International Financial Reporting Standards (“IFRS”).

The condensed interim financial statements are presented in New Zealand dollars which is the Company’s

functional and presentation currency, rounded to the nearest dollar.

The condensed interim financial statements are unaudited. The comparative information as at 31 March

2023 is audited.

2.2. Going concern

The Company incurred a net loss of $86,370 for the six months ended 30 September 2023 (six months

ended 30 September 2022: net loss $83,386) and generated negative operating cash flows of $61,595

(six months ended 30 September 2022: $59,050 negative). As at 30 September 2023 the Company has

reported net liabilities of $818,519 (31 March 2023: $795,721 net liabilities).

The considered view of the Board of Directors is that, after making enquiries, there is a reasonable

expectation that the Company will have access to adequate resources and commitments from its

creditors, that will enable it to meet its financial obligations for the foreseeable future. Accordingly, the

directors continue to adopt the going concern basis of accounting in preparing the interim financial

statements for the 6 months ended 30 September 2023.

The Company has a Loan Facility Agreement and Working Capital Loan Agreement with Excalibur Capital

Partners Limited (“Excalibur”) (refer note 6.1). Excalibur is a substantial shareholder in Ascension and is

controlled by S Joyce (a non-executive director of Ascension). As at 30 September 2023 the total liability

payable to Excalibur is $482,016 (31 March 2023: $479,641) and is shown as related party advances in

the Statement of Financial Position.

The Loan Facility Agreement is repayable on demand however, Excalibur has agreed to not make

demand unless and until the Company is in a position to repay the advance and pay its creditors as they

fall due. Excalibur has also confirmed that it anticipates most, if not all, of the $379,910 due from the



Ascension Capital Limited

Condensed Notes to the Interim Financial Statements

For the six months ended 30 September 2023


9

Company to Excalibur under this facility, may ultimately be converted into ordinary shares in Ascension in

the event of a reverse takeover transaction proceeding.

The Working Capital Loan Agreement with Excalibur provides a funding line of $95,000. At 30 September

2023 the Company had fully utilised this facility. The funds advanced under this loan agreement accrue

interest at a rate of 5% per annum. The loan becomes repayable when the Company completes a reverse

takeover transaction and is repayable either in new shares issued at the same price as the shares issued

for the reverse takeover transaction, or in cash, at the discretion of Excalibur.

As at 30 September 2023 the Company had $2,530 in cash and cash equivalents to settle trade payables

of $5,924 and accruals of $58,468. Of the $58,468, $45,000 relates to former director fees payable that

have been confirmed will not be called upon unless the Company has the means to pay the balance due.

Aside from the $21,519 term deposit that earns interest, the Company has no income earning assets from

which to derive revenue that may enable the Company to settle its obligations unless it is able to obtain

cash through the sale of further equity or a new business transaction.

The directors have agreed to forego payment of directors’ fees until such time as the Company has

sufficient funds to make such payments.

S Joyce has confirmed that he is willing and able to provide all reasonable financial support to the

Company to ensure that Ascension meets its obligations under the solvency test at section 4 of the

Companies Act 1993 for at least 12 months from the date the interim financial statements are approved.

On 20 October 2023 the Company received a further advance of $4,000 on the working capital loan from

Excalibur. This loan is under the same interest terms as previous working capital loan advances, with an

interest rate of 5% per annum (refer note 6.1). The advance will be utilised to fund the ongoing working

capital requirements of the Company while it continues to undertake investigations to find a suitable

business initiative to acquire via a reverse takeover transaction.

The Board of Directors acknowledge that there are material uncertainties with respect to the going

concern assumption. The focus of the Board going forward is to identify a suitable business opportunity to

invest in and/or acquire through a reverse takeover transaction. In the event that the cash received from

the loan advance noted above, is not sufficient to fund the operating expenses, or the Company is unable

to identify a suitable business opportunity to invest in and/or acquire, this would give rise to a material

uncertainty in relation to the Company’s ability to continue as a going concern. If the going concern

assumption is not valid, the Company may be unable to realise its assets and discharge its liabilities in the

normal course of business. The interim financial statements do not include any adjustments that may need

to be made should the Company no longer continue to be a going concern.

2.3. Accounting policies

The condensed interim financial statements have been prepared using the same accounting policies and

methods of computation detailed in the audited financial statements for the year ended 31 March 2023.

For details of the accounting policies please refer to the 2023 Annual Report.




Ascension Capital Limited

Condensed Notes to the Interim Financial Statements

For the six months ended 30 September 2023


10

3. Operating expenses



4. Segment reporting

The Company is organised into one operating segment and one geographical segment in New Zealand.

The operating segments are reported in a manner consistent with the internal reporting provided to the

chief operating decision maker. The chief operating decision maker is the Board of Directors.


5. Earnings per share





6 mths ended

6 mths ended

30 Sep 2023

30 Sep 2022

(unaudited)

(unaudited)

NZ$

NZ$

Directors' fees

(40,000)

(40,000)

NZX fees

(8,489)

(8,261)

Legal fees

(2,817)

(1,015)

Audit fees

(14,138)

(11,750)

Other expenses

(18,962)

(20,601)

(84,406)

(81,627)

6 mths ended

6 mths ended

30 Sep 2023

30 Sep 2022

(unaudited)

(unaudited)

Basic & diluted earnings/(loss) per share (NZ$):

From continuing operations

(0.00406)

(0.00435)

Total basic & diluted earnings/(loss) per share

(0.00406)

(0.00435)

6 mths ended

6 mths ended

30 Sep 2023

30 Sep 2022

NZ$

NZ$

Loss from continuing operations

(86,370)

(83,386)

(86,370)

(83,386)

21,279,323

19,148,881

Weighted average number of ordinary shares used in the calculation of

basic and diluted earnings per share

The profit/(loss) and weighted average number of ordinary shares used in the calculation of earrings/(loss)

per share are as follows:



Ascension Capital Limited

Condensed Notes to the Interim Financial Statements

For the six months ended 30 September 2023


11

6. Related parties

6.1. Related party advances



The related party advances are repayable to Excalibur Capital Partners Limited (“Excalibur”). Excalibur is

a substantial shareholder in Ascension and is controlled by S Joyce (a non-executive director of

Ascension).


Loan Facility Agreement

The loan facility is repayable on demand however, Excalibur has agreed to not make demand unless and

until the Company is in a position to repay the advance and pay its creditors as they fall due. This balance

is unsecured. Further, Excalibur has confirmed no interest is due or payable on the balance.


Working Capital Loan Agreement

On 10 November 2021 the Company entered into a Working Capital Loan Facility Agreement with

Excalibur. The funds advanced under this facility accrue interest at a rate of 5% per annum. The loan

becomes repayable when the Company completes a reverse takeover transaction and is repayable either

in new shares issued at the same price as the shares issued for the reverse takeover transaction, or in

cash, at the discretion of Excalibur. The loan is unsecured.



NZ$

Loan facility agreement:

Balance at 1 April 2022379,910

Loan advances received-

Balance at 31 March 2023 (audited)379,910

Loan advances received-

Balance at 30 September 2023 (unaudited)379,910

Working capital loan agreement:

Balance at 1 April 202225,521

Loan advances received70,000

Interest accrued at 5%4,210

Balance at 31 March 2023 (audited)99,731

Loan advances received-

Interest accrued at 5%2,375

Balance at 30 September 2023 (unaudited)102,106

Total related party advances:

At 31 March 2023479,641

At 30 September 2023

482,016



Ascension Capital Limited

Condensed Notes to the Interim Financial Statements

For the six months ended 30 September 2023


12

6.2. Directors’ remuneration



6.3. Payable to directors




The amounts payable to directors are payable on demand, however the directors have agreed to forego

payment of directors’ fees until such time as the Company has sufficient funds to make such payments.

No interest is accruing on the outstanding balances.


7. Reconciliation of loss after taxation with cash used in operating activities



6 mths ended

6 mths ended

30 Sep 2023

30 Sep 2022

(unaudited)

(unaudited)

NZ$

NZ$

K Jackson

10,000

10,000

J Cilliers

10,000

10,000

R Gower

10,000

10,000

S Joyce

10,000

10,000

40,000

40,000

30 Sep 2023

31 Mar 2023

(unaudited)

(audited)

NZ$

NZ$

Current directors

K Jackson

90,000

80,000

J Cilliers

90,000

80,000

R Gower

65,000

55,000

S Joyce

65,000

55,000

310,000

270,000

6 mths ended

6 mths ended

30 Sep 2023

30 Sep 2022

(unaudited)

(unaudited)

NZ$

NZ$

Net loss after taxation

(86,370)

(83,386)

Adjusted for:

Interest income

(411)

(136)

Interest on related party advances

2,375

1,896

Movements in working capital

(Increase) / decrease in other current assets

(9,031)

(9,050)

(Decrease) / increase in trade payables and other liabilities

31,843

31,626

Decrease / (increase) in taxation receivable

(1)

-

Net cash used in operating activities

(61,595)

(59,050)



Ascension Capital Limited

Condensed Notes to the Interim Financial Statements

For the six months ended 30 September 2023


13

8. Share capital

On 17 April 2023 the Company issued 2,350,000 new fully paid ordinary shares at an issue price of

$0.029 per share, to a number of wholesale investors. The placement raised $68,150 less share issue

costs of $4,578. The placement increased the total number of ordinary shares on issue to 21,498,828. All

issued shares are fully paid ordinary shares and carry one vote per share, carry a right to dividends and a

pro rata share of net assets on wind up.


9. Contingent liabilities

There are no contingent liabilities as at 30 September 2023 (31 March 2023: nil).


10. Commitments

There are no commitments as at 30 September 2023 (31 March 2023: nil)


11. Events subsequent to interim reporting date

On 20 October 2023 the Company received a further advance of $4,000 on the working capital loan from

Excalibur. This loan is under the same interest terms as previous working capital loan advances, with an

interest rate of 5% per annum (refer note 6.1).



Ascension Capital Limited

Company Directory



14


Company Number:

1009777


Incorporated

21 January 2000


Directors

K Jackson (Chair)

J Cilliers

R Gower

S Joyce


Registered Office

c/- Duncan Cotterill Lawyers

Level 5, Tower Building

50 Customhouse Quay

Wellington 6143


Bankers

ANZ Bank Ltd

23-29 Albert Street

Auckland 1010


Auditor

BDO Wellington Audit Ltd

Level 1, Tower Building

50 Customhouse Quay

Wellington 6143


Share Registry

Computershare Investor Services Ltd

Level 2, 159 Hurstmere Road

Takapuna

Ph: +64 9 488 8777

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • AGL — Accordant Group Limited: Accordant Group – Half Year Financial Performance
    2023-10-27

    Template Results announcement (for Equity Security issuer/Equity and Debt Security issuer) Updated as at June 2023 Please do not amend or delete individual rows. As this template relates to prescribed content, changes to content should only be made where…”

  • RTO — RTO Limited: Half Year Results
    2023-11-28

    Name of issuer Reporting Period Previous Reporting Period Currency Amount (000s) Revenue from continuing operations$10 Total Revenue$10 Net profit/(loss) from continuing operations -$125 Total net profit/(loss) -$125 Amount per Quoted Equity Security Imputed amount per Quoted Equ…”

  • BGP — Briscoe Group Limited: Half Year Results to 30 July 2023
    2023-09-12

    Results announcement Results for announcement to the market Name of issuer BRISCOE GROUP LIMITED Reporting Period Half-Year - 30 January 2023 to 30 July 2023 Previous Reporting Period Half-Year - 31 January 2022 to 31 July 2022 Currency New Zealand Dollars Amount…”